STUDIO CLINICO STML-401-0623
This section is dedicated to the patients of the retrospective study (0623) ("Study") sponsored by Stemline Therapeutics Inc ("Sponsor"), a company of the Menarini Group.
For each Country we have published the relevant information regarding how the Sponsor processes patients' data in the context of the study, as well as the list of hospitals (study sites) involved.